Discontinued — last reported Q4 '25
Biogen Other comprehensive income (loss), net of tax increased by 98.5% to $52.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 191.0%, from -$57.80M to $52.60M.
Significant fluctuations can indicate volatility in foreign exchange rates or the fair value of hedging instruments, which may impact future cash flows.
This represents revenues, expenses, gains, and losses that are excluded from net income under accounting standards but a...
Standard component of the Statement of Comprehensive Income for all companies reporting under GAAP/IFRS.
cat_other_comprehensive_income_net_of_tax| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$11.00M | $66.20M | $15.90M | $57.20M | $5.90M | -$35.40M | $6.90M | $29.60M | $14.70M | $20.10M | -$41.00M | -$57.80M | -$105.80M | $26.50M | $52.60M |
| QoQ Change | — | +701.8% | -76.0% | +259.7% | -89.7% | -700.0% | +119.5% | +329.0% | -50.3% | +36.7% | -304.0% | -41.0% | -83.0% | +125.0% | +98.5% |
| YoY Change | — | — | — | +620.0% | -91.1% | -322.6% | -87.9% | +401.7% | +141.5% | +191.3% | -238.5% | -493.2% | -626.4% | +164.6% | +191.0% |